Skip to content
Screener

Bruker BRKR Current Debt

Current Debt at other companies

Danaher logo
DanaherDHR
$1.41B+181%
Agilent Technologies logo
Agilent TechnologiesA
$304M+108%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$500K0.0%
Revvity logo
RevvityRVTY
$575.83M+237,847%
RadNet logo
RadNetRDNT
$26.51M+7.4%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$2M-99.9%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemJune 30,2026December 31,2025
Total assets$6,052.9$6,241.4
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and finance lease obligations$10.1$16.6
Accounts payable200.2215.9
Current portion of deferred revenue and customer advances444.6441.3
Other current liabilities549.8605.4
Total current liabilities1,204.71,279.2

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's current debt?
Bruker (BRKR) reported current debt of $10.1M in Q2 2026.
How has Bruker's current debt changed year-over-year?
Bruker's current debt decreased by 81.9% year-over-year, from $55.7M to $10.1M.
What is the long-term trend for Bruker's current debt?
Over 5 years (2020 to 2025), Bruker's current debt has grown at a 49.8% compound annual growth rate (CAGR), from $2.2M to $16.6M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Ask your AI about Bruker's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude